Skip to main content

Table 4 Healthcare resource use since diagnosis among patients with a primary diagnosis of CSU with or without angioedema

From: Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study

EU Region C/SA Region
Healthcare Resource CSU with angioedema (n = 1721) CSU without angioedema (n = 1760) Significance Test Statistic CSU with angioedema (n = 250) CSU without angioedema (n = 182) Significance Test Statistic
Emergency room
 Proportion of patients 40.4% 20.0% Chi2 = 175.474; Ρ < 0.001 54.0% 25.8% Chi2 = 38.379; P < 0.001
 Frequency of visits 4.0 (8.1) 2.5 (4.1) F = 9.70; Ρ = 0.002 8.0 (19.0) 2.1 (8.9) F = 13.42; P < 0.001
Hospitalizations
 Proportion of patients 29.1% 15.7% Chi2 = 90.023; Ρ < 0.001 11.4% 5.2% Chi2 = 4.913; P = 0.027
 Frequency of visits 2.3 (3.7) 1.5 (1.2) F = 9.69; Ρ = 0.002 0.4 (2.1) 0.2 (1.3) F = 1.86; P = 0.173
General practitioner
 Proportion of patients 61.9% 53.5% Chi2 = 24.977; Ρ < 0.001 38.1% 32.2% Chi2 = 1.547; P = 0.214
 Frequency of visits 9.5 (18.4) 5.8 (9.0) F = 27.72; Ρ < 0.001 2.3 (5.0) 1.1 (2.5) F = 8.34; P = 0.004
Dermatologist or allergist
 Proportion of patients 53.2% 41.2% Chi2 = 50.552; Ρ < 0.001 54.2% 54.0% Chi2 = 0.002;P = 0.966
 Frequency of visits 7.9 (26.6) 7.0 (22.3) F = 0.41; P = 0.523 5.3 (11.3) 5.9 (20.6) F = 0.13; P = 0.715